Saakshi Medtech & Panels Board of Directors

Get the latest insights into the leadership at Saakshi Medtech & Panels. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Aniket Vijay Latkar Managing Director
Ms. Chitra Vijay Latkar Non Executive Director
Ms. Mayuri Aniket Latkar WholeTime Director & CFO
Mr. Amit Yashavant Ghaisas Independent Director
Mr. Vishvas Vinayak Palande Independent Director

Saakshi Medtech & Panels Share price

SAAKSHI

169

2.00 (-1.17%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:28 IST
BUYSELL
Today's High

171.90

Today's Low

167.30

52 Week Low

118.00

52 Week High

268.40

The current prices are delayed, login to your account for live prices

Saakshi Medtech & Panels FAQs

The board at Saakshi Medtech & Panels consists of experienced professionals, including Mr. Aniket Vijay Latkar , Ms. Chitra Vijay Latkar , and others, overseeing the company’s strategic and corporate governance.

Directors at Saakshi Medtech & Panels are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Aniket Vijay Latkar is the current chairman at Saakshi Medtech & Panels.

Executive directors at Saakshi Medtech & Panels are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Saakshi Medtech & Panels adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Saakshi Medtech & Panels, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.